D Harold, R Abraham, P Hollingworth, R Sims… - Nature …, 2009 - nature.com
We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD) involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 …
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous studies; however, a large portion of the genetic risk for this disease remains …
K Bettens, N Brouwers, S Engelborghs… - Molecular …, 2012 - Springer
Background We have followed-up on the recent genome-wide association (GWA) of the clusterin gene (CLU) with increased risk for Alzheimer disease (AD), by performing an …
Objectives: To determine whether genotypes at CLU, PICALM, and CR1 confer risk for Alzheimer disease (AD) and whether risk for AD associated with these genes is influenced …
L Bertram, RE Tanzi - Human molecular genetics, 2004 - academic.oup.com
The research of Alzheimer's disease (AD) genetics has been extremely prolific over the past decade, and currently more than 10 genes are reported to show either positive or negative …
Alzheimer's disease (AD) is a devastating neurodegenerative disorder of late life with complex inheritance. Mutations in three known genes lead to the rare early-onset autosomal …
JC Lambert, P Amouyel - Current opinion in genetics & development, 2011 - Elsevier
Alzheimer's disease (AD) is the prime cause of dementia and presents a strong genetic predisposition (60–80% of the attributable risk). In addition to APOE, a major recognized …
Abstract Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated …
L Bertram, C Lange, K Mullin, M Parkinson… - The American Journal of …, 2008 - cell.com
Alzheimer's disease (AD) is a genetically complex and heterogeneous disorder. To date four genes have been established to either cause early-onset autosomal-dominant AD (APP …